FormuMax provides specialized contract research services focused on liposomes and lipid nanoparticles (LNPs). Our team collaborates with pharmaceutical, biotechnology, and academic researchers to develop stable, reproducible formulations suitable for preclinical research and development.
We support projects ranging from early feasibility studies to optimized liposome/LNP formulations. Our work integrates formulation development, and analytical characterization to accelerate the development of lipid-based delivery systems.
To learn more about our services please go to www.liposomes.com
Formulation Development
-
Specialized in difficult-to-formulate compounds
-
Liposomes and other lipid-based drug delivery systems
-
Controlled/slow drug release systems
-
Nanocrystal down-sizing and polymer coating
- LNP formulation for mRNA delivery
-
Pre-formulation, formulation feasibility, and prototype development
-
Scale-up and optimization
-
Extrusion, homogenization/microfluidization, sonication and others
-
Formulation characterization, stability, in vitro/in vivo studies
-
Lyophylization
-
Optimization of formulation process and carrier matrix
-
Formulation development for pharmaceuticals, cosmetics and nutraceuticals
Analytical Science, Charaterization and non-clinical
-
Formulation physical characterization
-
Particle size and distribution (by QELS and/or EM)Zeta Potential
-
Encapsulation efficiency
-
Electron-microscopy (cryo-EM, Freeze-fracture-EM)
-
Osmolility
-
-
HPLC method development (HPLC-CAD)
-
Formulation chemical and physical stability
-
In vitro drug release assay
-
Nonclinical studies (PK, anti-tumor efficacy)
- Formulation assessment